Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.33 |
| ▸ | LMNA | P02545 | 3/20 | 0.33 |
| ▸ | GAA | P10253 | 3/20 | 0.33 |
| ▸ | POLB | P06746 | 3/20 | 0.33 |
| ▸ | MAPT | P10636 | 3/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 2/20 | 0.32 |
| ▸ | EED | O75530 | 1/20 | 0.31 |
| ▸ | SUZ12 | Q15022 | 1/20 | 0.31 |
| ▸ | EZH2 | Q15910 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
| ▸ | EPAS1 | Q99814 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26383029 | 0.92 | SMN1; SMN2 (0.35) | SMN1; SMN2KMT2AMEN1NPSR1KDM4E | |
| SCHEMBL10046851 | 0.74 | EED (0.42) | SMN1; SMN2KMT2AMEN1NPSR1MAPT | |
| SCHEMBL5352623 | 0.74 | EED (0.42) | SMN1; SMN2KMT2AMEN1NPSR1MAPT | |
| SCHEMBL6902793 | 0.73 | EED (0.41) | SMN1; SMN2KMT2AMEN1NPSR1LMNA | |
| SCHEMBL20424094 | 0.73 | SMN1; SMN2 (0.34) | SMN1; SMN2KMT2AMEN1KDM4EALDH1A1 | |
| SCHEMBL7550154 | 0.73 | NPSR1 (0.41) | SMN1; SMN2KMT2AMEN1NPSR1MAPT | |
| SCHEMBL28218027 | 0.73 | NPSR1 (0.41) | SMN1; SMN2KMT2AMEN1NPSR1MAPT | |
| SCHEMBL21114903 | 0.72 | FFAR3 (0.39) | SMN1; SMN2NPSR1KDM4ELMNAPOLB | |
| SCHEMBL17317465 | 0.71 | KMT2A (0.36) | SMN1; SMN2KMT2AMEN1NPSR1KDM4E | |
| SCHEMBL18101499 | 0.71 | CYP3A4 (0.38) | SMN1; SMN2KMT2AMEN1NPSR1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3634430-B1 | MULTIBIOTIC AGENTS AND METHODS OF USING THE SAME | FLAGSHIP PIONEERING INNOVATIONS V INC (US) | 2024-08-07 | — | — | EP | disclosed |
| US-20240158567-A1 | ALL-PURPOSE POLY(3-HYDROXYBUTYRATE) BY STEREOMICROSTRUCTURAL ENGINEERING | UNITED STATES DEPARTMENT OF ENERGY | 2024-05-16 | — | — | US | disclosed |
| US-20230312815-A1 | SYNTHESIS OF POLYMERS FROM CYCLIC DIOLIDES | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2023-10-05 | — | — | US | disclosed |
| US-20230312815-A1 | SYNTHESIS OF POLYMERS FROM CYCLIC DIOLIDES | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2023-10-05 | — | — | US | disclosed |
| US-20230293458-A1 | MULTIBIOTIC AGENTS AND METHODS OF USING THE SAME | FLAGSHIP PIONEERING INNOVATIONS V INC (US) | 2023-09-21 | — | — | US | disclosed |
| US-11629223-B2 | Synthesis of polymers from cyclic diolides | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2023-04-18 | — | — | US | disclosed |
| US-20210206912-A1 | SYNTHESIS OF POLYMERS FROM CYCLIC DIOLIDES | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2021-07-08 | — | — | US | disclosed |
| US-20210206912-A1 | SYNTHESIS OF POLYMERS FROM CYCLIC DIOLIDES | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2021-07-08 | — | — | US | disclosed |
| US-10954335-B2 | Synthesis of crystalline polymers from cyclic diolides | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2021-03-23 | — | — | US | disclosed |
| US-10954335-B2 | Synthesis of crystalline polymers from cyclic diolides | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2021-03-23 | — | — | US | disclosed |
| US-20200101030-A1 | MULTIBIOTIC AGENTS AND METHODS OF USING THE SAME | KINTAI THERAPEUTICS, INC. | 2020-04-02 | — | — | US | disclosed |
| CN-110869024-A | Multi-biological agents and methods of use thereof | 旗舰创业创新五公司 | 2020-03-06 | — | — | CN | disclosed |
| US-20190211144-A1 | SYNTHESIS OF CRYSTALLINE POLYMERS FROM CYCLIC DIOLIDES | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2019-07-11 | — | — | US | disclosed |
| US-20190211144-A1 | SYNTHESIS OF CRYSTALLINE POLYMERS FROM CYCLIC DIOLIDES | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2019-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200101030-A1 | MULTIBIOTIC AGENTS AND METHODS OF USING THE SAME | SI, FABP2, CEL | SMN1; SMN2 2598/4885KMT2A 1842/4885MEN1 2289/4885 |
| US-20230293458-A1 | MULTIBIOTIC AGENTS AND METHODS OF USING THE SAME | SI, FABP2, CEL | SMN1; SMN2 2598/4885KMT2A 1842/4885MEN1 2289/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.